Load balancing the GRID ad-hoc routing protocol

by Bloom, Rebecca S. (Rebecca Spangenthal), 1981-
Published 2005

Once-daily indacaterol 75 µg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect

by Siler TM, LaForce CF, Kianifard F, Williams J, Spangenthal S
Published 2014-09-01

A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in p...

by Edward M. Kerwin, Selwyn Spangenthal, Christine Kollar, Earl St Rose, Colin Reisner
Published 2018-03-01

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

by LaForce C, Feldman G, Spangenthal S, Eckert JH, Henley M, Patalano F, D’Andrea P
Published 2016-06-01

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

by Courtney Crim, Mark Gotfried, Selwyn Spangenthal, Michael Watkins, Amanda Emmett, Catriona Crawford, Charlotte Baidoo, Ramiro Castro-Santamaria
Published 2020-05-01

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia

by Pankit Vachhani, Sarah Shin, Jeffrey Baron, James E. Thompson, Meir Wetzler, Elizabeth A. Griffiths, Evelena P. Ontiveros, Edward J. Spangenthal, Eunice S. Wang
Published 2017-01-01

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

by Nikhil Agrawal, Arjun Khunger, Pankit Vachhani, Teresa A. Colvin, Alexander Hattoum, Edward Spangenthal, Anne B. Curtis, Grace K. Dy, Marc S. Ernstoff, Igor Puzanov
Published 2019-03-01

Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspe...

by Colin Reisner, Leonardo M. Fabbri, Edward M. Kerwin, Charles Fogarty, Selwyn Spangenthal, Klaus F. Rabe, Gary T. Ferguson, Fernando J. Martinez, James F. Donohue, Patrick Darken, Earl St. Rose, Chad Orevillo, Shannon Strom, Tracy Fischer, Michael Golden, Sarvajna Dwivedi
Published 2017-08-01

Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

by Edward J Spangenthal, Pankit Vachhani, Fumito Ito, Ankita Kapoor, Poornima Subramanian, Yan V Yatsynovich, David M Jacobs, Maya R Chilbert, Umesh C Sharma, Steven G Feuerstein, Filip Stefanovic, Mark D Hicar, Anne B Curtis, Grace K Dy, Brian J Page, Nikhil Agrawal, Arjun Khunger, Alexander Hattoum, Schentag J Jerome
Published 2021-06-01